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Abstract
Purpose Autologous skin substitutes to cover large skin
defects are used since several years. Melanocytes, although
essential for solar protection and pigmentation of skin, are
not yet systematically added to such substitutes. In this
experimental study, we reconstructed melanocyte-contain-
ing dermo-epidermal skin substitutes from donor skins of
different skin pigmentation types and studied them in an
animal model. Features pertinent to skin color were ana-
lyzed and compared in both skin substitutes and original
donor skin.
Methods Keratinocytes, melanocytes, and fibroblast were
isolated, cultured, and expanded from skin biopsies of light-
and dark-pigmented patients. For each donor, melanocytes
and keratinocytes were seeded in different ratios (1:1, 1:5,
1:10) onto collagen gels previously populated with autolo-
gous fibroblasts. Skin substitutes were then transplanted
onto full-thickness wounds of immuno-incompetent rats.
After 8 weeks, macroscopic and microscopic analyses were
conducted with regard to skin color and architecture.
Results Chromameter evaluation revealed that skin color
of reconstructed light- and dark-pigmented skin was very
similar to donor skin, independent of which melanocyte/
keratinocyte ratio was added. Histological analyses of the
skin analogs confirmed these findings.
Conclusion These data suggest that adding autologous
melanocytes to bioengineered dermo-epidermal skin ana-
logs can sustainably restore the patients’ native skin color.
Keywords Melanocytes  Melanocyte/keratinocyte ratio 
Tissue engineering  Skin analog  Skin color  Rat model
Introduction
One promising approach to cover large full-thickness skin
defects is tissue engineering of skin [1]. Several laborato-
ries worldwide, including our own research group, have
been working on this ambitious project and have made
substantial progress over the last years [2–5].
At our center, we first used simple autologous cultured
epidermal autografts (CEA) for burn and reconstructive
surgery [6, 7]. However, they did not fulfill the expecta-
tions in that they showed inconsistent CEA take as well as
inconsistent functional and esthetic results. Consequently,
we invested several years on the development of a near
natural dermo-epidermal skin equivalent, based on the
hypothesis that a skin substitute closely resembling native
skin might ultimately produce more satisfactory clinical
results [8–10]. Then, we managed to bioengineer capillar-
ies in vitro in order to prevascularize [11]. Also, we looked
at numerous options to strengthen the dermal compartment
for better surgical handling and are now successfully
working with a compressed hydrogel that serves as dermal
template [12]. Finally, and with clinical application
in mind, we developed a system to produce large scale
(7.5 9 7.5 cm) skin analogs that were favorably tested in a
large animal model (pig) [2, 3].
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Most recently, we directed our work also at pigmenta-
tion that, for obvious reasons, is a crucial issue since it
plays a fundamental functional role in terms of skin pro-
tection against ultraviolet (UV) radiation, and, in addition,
it has a paramount cosmetic impact for the patient. If
melanocytes, the cells responsible for skin pigmentation,
are missing in skin analogs, the grafts appear unnaturally
white like vitiligo-affected areas [13]. Therefore, we have
designed a project with the principal goal to provide our
autologous human skin analogs with appropriate pigmen-
tation matching as closely as possible the native color
present at the presumptive site of transplantation. To
achieve this goal, we added human melanocytes in differ-
ent ratios to the epidermal compartment of laboratory-
engineered, human dermo-epidermal skin analogs, tested
these in a rat model, and compared the obtained pigmen-
tation features to those of the original donor skin.
Materials and methods
Human skin samples
The study was conducted according to the ‘‘Declaration of
Helsinki Principles’’ and after permission by the ethic
commission of the Canton Zurich. Parents or patients gave
informed consent to use skin samples. The human foreskins
used were obtained from light and dark skin pigmentation
types from patients 1–16 years of age. The skin samples
were used for the isolation of human epidermal keratino-
cytes, melanocytes, and dermal fibroblasts. Tissues sam-
ples for histological examinations were embedded in OCT
compound (Sakura Finetek, Switzerland) and kept at
-30 C, or prepared for paraffin sections.
Isolation and culturing of primary cells
Keratinocytes and fibroblasts were isolated and cultured as
described in Pontiggia et al. [10], and melanocytes as
specified in Bo¨ttcher-Haberzeth et al. [8].
Preparation of tissue engineered skin analogs
The skin analogs were prepared as previously described
[10]. Briefly, rat collagen type I was mixed with 1 9 105
human dermal fibroblasts (passage 1) and placed in cell
culture inserts with membranes of 3.0 lm pore-size (all BD
Falcon, Germany). These dermal equivalents were grown in
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen,
Switzerland) for 6 days to allow for gel contraction. On
each dermal equivalent 5 9 105 keratinocytes and mela-
nocytes (passage 1) of the corresponding donor skin were
seeded in different ratios (melanocytes:keratinocytes 1:1,
1:5, or 1:10). The skin analogs were cultured for 1 week in
a 1:1 mix of keratinocyte medium (SFM, Invitrogen,
Switzerland) and melanocyte growth medium (Promocell,
Germany), and subsequently transplanted (Table 1).
Transplantation of tissue engineered skin analogs
The surgical protocol was approved by the local Commit-
tee for Experimental Animal Research (permission number
76/2011). Immuno-incompetent female nu/nu rats, 8–10
weeks old (Harlan Laboratories, Netherlands), were pre-
pared and anesthetized as previously described [14, 15].
Skin analogs were transplanted onto full-thickness skin
defects created surgically on the backs of the rats. To
prevent wound closure from surrounding rat skin and to
protect the skin analogs, surgical steel rings (26 mm in
diameter) were sutured to the skin defects using non-
absorbable polyester sutures (Ethibond, Ethicon, USA).
The skin analogs were covered with a silicone foil (Silon-
SES, BMS, USA), a polyurethane sponge (Ligasano, Lig-
amed, Austria), and a tape as wound dressing. Dressing
changes and photographic documentations were performed
once per week. After 8 weeks, the transplanted skin ana-
logs were excised in toto and processed for cryo- and
paraffin sections and electron microscopy.
Chromameter measurements
The International Commission on Illumination (Commis-
sion internationale de l’Eclairage, CIE) principles of
1976 describes a uniform, three-dimensional color space
(L*a*b*) because color vision is trichromatic. The L value
correlates to perceived lightness. It can range from absolute
black (0) to absolute white (?100). As it is the most sen-
sitive of the trichromatic values to skin analog color change,
only the L value (mean ± SD) of the reflectance spectros-
copy used to measure the visible spectrum of light reflected
from the patients’ foreskins and skin analogs was recorded
in this study. The spectroscopy was conducted by employ-
ing a Chromameter CR-200 (Minolta, Osaka, Japan).
Histological analysis
Paraffin sections (5 lm) were stained with hematoxylin
and eosin (Sigma, Switzerland) to assess the histological
morphology and with the Fontana Masson technique to
visualize melanin [16] in the transplanted skin analogs.
Immunohistochemical staining
Immunofluorescence staining was performed as described
in Bo¨ttcher-Haberzeth et al. [8, 15]. To detect melano-
somes, an anti-melanosome antibody was used (HMB-45,
240 Pediatr Surg Int (2013) 29:239–247
123
1:50, Dako, Switzerland). To visualize the basement
membrane, a staining against laminin-5 was performed
(clone P3H9-2, 1:100, Santa Cruz, Germany). Pictures
of immunofluorescence stainings were taken with a
DXM1200F digital camera connected to a Nikon Eclipse
TE2000-U inverted microscope. The device is equipped
with Hoechst 33342-, FITC-, and TRITC-filter sets (Nikon
AG, Switzerland; Software: Nikon ACT-1 vers. 2.70).
Images were processed with Photoshop 7.0 (Adobe Sys-
tems Inc, Germany).
Electron microscopy
For transmission electron microscopy analyses, tissue blocs
(approximately 1 mm3) were prefixed in 0.1 M cacodylate
buffer (Merck, Germany), pH 7.3 containing 2.5 %
glutaraldehyde for 2 h, washed in cacodylate buffer, post-
fixed with an aqueous solution of 1 % OsO4 and 1.5 %
K4Fe(CN)6 for 1 h, dehydrated, and finally embedded in
EPON 812 (Catalys AG, Switzerland). Ultrathin sections
(approximately 50–70 nm) were collected on copper grids,
contrasted with 4 % uranyl acetate and 3 % lead citrate,
and examined with a CM 100 transmission electron
microscope (Philips, The Netherlands). All reagents were
from Sigma unless mentioned otherwise.
Statistical analysis
Melanocytes in the basal layer of the donor skin and of the
skin analogs were evaluated by counting HMB-45 positive
cells and cell nuclei (Hoechst staining) four times in each
of five representative sections from each skin sample. The
results were calculated (Microsoft Excel) to display the
mean ± SD graphically.
Results
Macroscopic appearance and color measurement
of transplants
Eight weeks after transplantation, the reconstructed human
skin analogs from light- and dark-pigmented donor skin
showed a strong resemblance to the latter regarding color
and structure, independent of which melanocyte/keratino-
cyte ratio was used (Fig. 1). Pigmentation was very
homogenous and even throughout the entire transplant of
all specimens. The chromameter evaluation (L value) of the
reconstructed light skin showed a mean deviation from the
native light skin of 4.33 % (SD 1.91 %) for the constructs
with a 1:1 melanocyte/keratinocyte ratio, of 3.68 % (SD
0.63 %) for the constructs with a 1:5 melanocyte/kerati-
nocyte ratio, and of 1.91 % (SD 3.27 %) for the constructs
with a 1:10 melanocyte/keratinocyte ratio. The chromam-
eter evaluation of the reconstructed dark skin showed
a mean deviation from the native dark skin of 2.04 %
(SD 0.96 %) for the constructs with a 1:1 melanocyte/
keratinocytes ratio, of 3.26 % (SD 7.94 %) for the con-
structs with a 1:5 melanocyte/keratinocyte ratio, and of
0.71 % (SD 5.55 %) for the constructs with a 1:10 mela-
nocyte/keratinocyte ratio.
Epidermal structure
The epidermis of the constructs was comparable to the
histology of the donor skin with regard to epidermal
stratification, cellular differentiation, and absence of
parakeratotic cells (Fig. 2). Results were very similar in
both light and dark skin. A noticeable difference between
the two was the heavily pigmented basal layer of the dark
skin. An obvious difference between the analogs and the
donor skin was the absence of rete ridges in the engi-
neered skin.
Melanocytes and melanogenesis
HMB-45 staining visualized the melanocytes in the epi-
dermis of the constructs (arrowheads Fig. 3). They resided
in a physiologic position in the basal layer with contact to
the basal membrane and projected dendrites into the upper
layers of the epidermis (arrows Fig. 3). Fontana Masson
staining demonstrated the typical melanin distribution
within epidermal cells (supranuclear melanin cap) (Fig. 4).
There were distinct differences between the light- and
dark-pigmented constructs: there was more melanin in dark
constructs and, in contrast to light constructs, melanin was
Table 1 Overview of the study
design
N number of skin analogs
prepared for transplantation
Melanocytes:Keratinocytes Melanocytes:Keratinocytes Melanocytes:Keratinocytes
1:1 1:5 1:10
Light skin
analogs, N = 9
(total)
1 4 4
Dark skin
analogs, N = 9
(total)
1 4 4
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found in all epidermal layers. Generally, the engineered
constructs showed similar melanin quantities and distri-
bution to the donor skin, independent of which melanocyte/
keratinocyte seeding ratio was used.
By transmission electron microscopy, the melanosomes
inside melanocytes and their dendrites as well as melanin
inside keratinocytes was analyzed more in detail (Fig. 5):
in the light skin analogs, melanocytes produced less mel-
anin and lighter melanin granules in the melanosomes,
whereas melanocytes in the dark skin analogs produced
more melanin and darker melanin granules in the mela-
nosomes. The keratinocytes of the light skin constructs
Fig. 1 Macroscopic view of
light and dark donor skin and its
corresponding tissue engineered
skin analogs 8 weeks after
transplantation. a Light and
b dark donor skin before tissue
preparation for cell isolation;
c, e, g tissue engineered skin
analogs of light skin with a
melanocyte/keratinocyte ratio of
1:1, 1:5, and 1:10; d, f, h tissue
engineered skin analogs of
dark skin with a melanocyte/
keratinocyte ratio of 1:1, 1:5,
and 1:10. All analogs show a
similar color to its donor skin,
independent of which
melanocyte/keratinocyte ratio
was used initially
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contained less pigment than the ones of the dark skin
constructs. In both analogs, melanin was arranged in a
supranuclear position (supranuclear cap).
Melanocyte density
The melanocyte/keratinocyte ratio in the basal layer of all
analogs was very similar to that in the corresponding donor
skin. Results in both, the light- and dark-pigmented skin
analogs, were independent of which melanocyte/keratino-
cyte ratio had been added initially (Fig. 6).
Discussion
This is an experimental study looking at the question whether
the original, i.e. ‘‘constitutive’’, skin color of a patient can be
reproduced when melanocytes are added to tissue engineered
Fig. 2 Histological evaluation
of light and dark donor skin and
of excised corresponding tissue
engineered skin analogs
8 weeks after transplantation
(hematoxylin and eosin
staining). a Light and b dark
donor skin; c, e, g tissue
engineered skin analogs of light
skin with a melanocyte/
keratinocyte ratio of 1:1, 1:5,
and 1:10; d, f, h tissue
engineered skin analogs of dark
skin with a melanocyte/
keratinocyte ratio of 1:1, 1:5,
and 1:10. All analogs show a
well developed, stratified
epidermis very comparable to
the corresponding donor skin
structure. In the dark skin
analogs, the heavily pigmented
basal layer can easily be
detected. Scale bars 50 lm
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full-thickness skin analogs. In particular, we looked at the
results of reconstructed light- and dark-pigmented skin types
when all cell types used (keratinocytes, melanocytes, and
fibroblasts) were taken from the same donor skin and mela-
nocytes were added in different ratios. Generally speaking,
this study demonstrates that providing bioengineered skin
analogs with melanocytes does in fact result in a skin color
that is not only subjectively (photographic documentation)
but also objectively (chromameter evaluation) almost iden-
tical to the color of the native donor skin. A number of
aspects call for a detailed comment.
The fact that normal skin color is restored in our skin
substitutes indicates that all sophisticated and often multi-
step maneuvers from removal of the skin biopsy to cell
isolation and culture, to assemblage of the substitutes, to
transplantation, to middle-term maturation of the human
transplanted skin in a rat model, do not seem to alter the
involved cells (keratinocytes, melanocytes, and fibroblasts)
in any measurable way. These cells apparently maintain
their inherent programs enabling them to communicate and
interact with each other and work as a functional epidermal
melanin unit (EMU) [17, 18].
Interestingly, the above mentioned color production is
independent of the original number of melanocytes added
to the constructs. Even a significant deviation from the
physiological 1:5 ratio of melanocytes to keratinocytes in
the basal layer toward a higher (1:1) and a lower ratio
(1:10) of melanocytes to keratinocytes does not result in
any measurable color difference. It is known that a mini-
mum density of melanocytes is required to restore pig-
mentation completely [13]. In our analogs, this minimum
number of melanocytes necessary to enable pigmentation
of the skin was used.
On a histological level, the macroscopic findings were
precisely reflected. Particularly relevant is the fact that
melanogenesis and the distribution of melanin transferred
to keratinocytes very closely resembled the well-docu-
mented pattern known from physiological EMUs [19–21].
Also, the typical differences between light- and dark-pig-
mented skin types [21, 22] such as poorly pigmented
supranuclear melanosomes and melanosome-free upper
epidermis in light skin as well as heavily pigmented mel-
anosomes throughout the cytoplasm of keratinocytes and
melanosome presence throughout the entire epidermis in
dark skin were largely replicated in our skin analogs.
Taken together, there is compelling evidence that adding
melanocytes to bioengineered skin substitutes results in an
almost physiological restoration of those cellular and
molecular processes usually involved in the complex
dynamics of skin pigmentation.
The importance of using all three cell types (keratino-
cytes, melanocytes, and fibroblasts) from the same donor
skin must also be highlighted. It is known that keratino-
cytes, melanocytes, and fibroblasts are highly interactive
and communicate with each other via cell/cell contacts and
secreted factors to regulate skin phenotype and function-
ality [21]. In this context, it is crucial to underline the
importance of using these three key player cells from the
same donor skin sample (as shown here) to reproduce the
original skin color in bioengineered skin analogs. Inter-
estingly, combining keratinocytes and melanocytes from
one skin pigment type with fibroblasts from another skin
pigment type results in disparate skin colors of engineered
skin substitutes [22]. Clearly, for clinical applications, the
requirement for fully autologous skin substitutes is indis-
pensable for obvious reasons.
With regard to skin physiology, the novel possibility to
provide tissue engineered skin analogs with a near natural
color represents a significant progress not only in general
terms of cosmesis, but especially in terms of cancer
Fig. 3 Melanocyte position in light and dark tissue engineered skin
analogs 8 weeks after transplantation. a Representative image of a
light tissue engineered skin analog, b representative image of a dark
tissue engineered skin analog. Melanocytes are stained with HMB-45
(green), the basement membrane with Laminin-5 (red), cell nuclei are
stained with Hoechst (blue). Melanocytes are distributed throughout
the basal layer (arrowheads) on the basement membrane. Dendrites
can be seen projecting to the upper layers of the epidermis (white
arrows). Scale bars 50 lm
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prevention and the potential to correct stigmatizing pig-
mentation defects [23, 24].
This study, however, does not address all important
issues regarding this topic. First, we did not generate any
data demonstrating that tissue engineered EMUs possess the
ability to appropriately react to UV radiation. Definitely, the
well-documented up- and down-regulation processes (e.g.
PAR-2 receptor expression, melanin production) must be
studied in this context [25–28]. Secondly, this study does
not provide long-term data. Although the results shown here
are amazingly physiological and although there are no
obvious reasons why this functional capability should sig-
nificantly change over time, formal long-term studies must
address the question whether hypo- or hyperpigmentation
may occur over time [13, 29]. Finally, the evergreen-issue
of whether manipulating melanocytes is associated with an
increased risk of eventual melanoma-formation must be
mentioned. Even though our study period is definitely not
sufficiently long to answer these questions and even though
we have not looked in detail at markers used for melanoma
Fig. 4 Fontana Masson
staining of light and dark donor
skin and of the excised
corresponding tissue engineered
skin analogs 8 weeks after
transplantation. a Light and
b dark donor skin; c, e, g tissue
engineered skin analogs of light
skin with a melanocyte/
keratinocyte ratio of 1:1, 1:5,
and 1:10; d, f, h tissue
engineered skin analogs of dark
skin with a melanocyte/
keratinocyte ratio of 1:1, 1:5,
and 1:10. Melanin granules stain
black. Melanin quantity and
distribution in skin analogs is
very comparable to the
corresponding donor skin,
however, much more
pronounced in dark skin
analogs. Melanin is
physiologically arranged as
supranuclear caps in all
transplants. Scale bars 50 lm
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diagnostic work-up (e.g. S100, Melan A, Ki67), we have not
found any irritating histological features indicative of
melanocyte dysplasia such as epidermal cluster-formation
or dermal compartment invasion.
In conclusion, this is, to the best of our knowledge, the
first study demonstrating that adding autologous melano-
cytes to tissue engineered full-thickness skin analogs
allows the so reconstructed skin to produce a near normal
skin color almost identical to the native color present in the
donor skin. It appears crucial that all three cell types
originate from the same donor skin. These findings have
significant clinical implications in that transplanting a skin
analog containing functional EMUs is much more physi-
ological, protects against harmful UV radiation, and
improves cosmetic outcome.
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